Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 585

2.

Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: an observational study.

Anandam A, Patil M, Akinnusi M, Jaoude P, El-Solh AA.

Respirology. 2013 Nov;18(8):1184-90. doi: 10.1111/resp.12140.

PMID:
23731062
3.

Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure.

Sharples L, Glover M, Clutterbuck-James A, Bennett M, Jordan J, Chadwick R, Pittman M, East C, Cameron M, Davies M, Oscroft N, Smith I, Morrell M, Fox-Rushby J, Quinnell T.

Health Technol Assess. 2014 Oct;18(67):1-296. doi: 10.3310/hta18670.

4.

Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study.

Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM.

Ann Intern Med. 2012 Jan 17;156(2):115-22. doi: 10.7326/0003-4819-156-2-201201170-00006.

PMID:
22250142
5.

Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment.

Martínez-García MA, Campos-Rodríguez F, Soler-Cataluña JJ, Catalán-Serra P, Román-Sánchez P, Montserrat JM.

Eur Respir J. 2012 Apr;39(4):906-12. doi: 10.1183/09031936.00011311. Epub 2011 Sep 29.

6.

Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial.

Durán-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Terán-Santos J, Aguirregomoscorta JI, Gonzalez M, Lloberes P, Masa JF, De La Peña M, Carrizo S, Mayos M, Barbé F; Spanish Sleep and Breathing Group.

BMJ. 2010 Nov 24;341:c5991. doi: 10.1136/bmj.c5991.

PMID:
21106625
7.

Adequate continuous positive airway pressure therapy reduces mortality in Chinese patients with obstructive sleep apnea.

Yuan X, Fang J, Wang L, Yao L, Li L, Zhan X, Wu H, Pinto JM, Wei Y.

Sleep Breath. 2015 Sep;19(3):911-20. doi: 10.1007/s11325-014-1091-9. Epub 2014 Dec 9.

PMID:
25487312
8.

[Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome].

Drummond M, Winck J, Guimarães J, Santos AC, Almeida J, Marques J.

Arch Bronconeumol. 2009 Dec;45(12):577-84. doi: 10.1016/j.arbres.2009.05.002. Epub 2009 Jun 23. Spanish.

9.

Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive sleep apnoea/hypopnoea syndrome in the UK.

Guest JF, Helter MT, Morga A, Stradling JR.

Thorax. 2008 Oct;63(10):860-5. doi: 10.1136/thx.2007.086454. Epub 2008 Apr 11. Review.

PMID:
18408048
10.

Obstructive Sleep Apnoea Syndrome: A Systematic Literature Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2007 Jun.

11.

Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study.

Martínez-García MA, Campos-Rodríguez F, Catalán-Serra P, Soler-Cataluña JJ, Almeida-Gonzalez C, De la Cruz Morón I, Durán-Cantolla J, Montserrat JM.

Am J Respir Crit Care Med. 2012 Nov 1;186(9):909-16. doi: 10.1164/rccm.201203-0448OC. Epub 2012 Sep 13.

PMID:
22983957
12.

Influence of moderate alcohol consumption on obstructive sleep apnoea with and without AutoSet nasal CPAP therapy.

Teschler H, Berthon-Jones M, Wessendorf T, Meyer HJ, Konietzko N.

Eur Respir J. 1996 Nov;9(11):2371-7.

13.

Continuous positive airway pressure therapy lowers vagal tone in patients with obstructive sleep apnoea-hypopnoea syndrome.

Chrysostomakis SI, Simantirakis EN, Schiza SE, Karalis IK, Klapsinos NC, Siafakas NM, Vardas PE.

Hellenic J Cardiol. 2006 Jan-Feb;47(1):13-20.

14.

Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial.

Johansson K, Neovius M, Lagerros YT, Harlid R, Rössner S, Granath F, Hemmingsson E.

BMJ. 2009 Dec 3;339:b4609. doi: 10.1136/bmj.b4609.

15.

Continuous positive airways pressure for obstructive sleep apnoea in adults.

Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001106. Review.

PMID:
16855960
16.

Continuous positive airways pressure for obstructive sleep apnoea in adults.

Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001106. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD001106.

PMID:
16437429
17.

Continuous positive airway pressure in clinically stable patients with mild-to-moderate obesity hypoventilation syndrome and obstructive sleep apnoea.

Salord N, Mayos M, Miralda RM, Farré A, Carreras M, Sust R, Masuet-Aumatell C, Rodríguez J, Pérez A.

Respirology. 2013 Oct;18(7):1135-42. doi: 10.1111/resp.12131.

PMID:
23714281
18.

Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.

Mason M, Cates CJ, Smith I.

Cochrane Database Syst Rev. 2015 Jul 14;(7):CD011090. doi: 10.1002/14651858.CD011090.pub2. Review.

PMID:
26171909
19.

Longer term effects of very low energy diet on obstructive sleep apnoea in cohort derived from randomised controlled trial: prospective observational follow-up study.

Johansson K, Hemmingsson E, Harlid R, Trolle Lagerros Y, Granath F, Rössner S, Neovius M.

BMJ. 2011 Jun 1;342:d3017. doi: 10.1136/bmj.d3017.

20.

Diurnal changes and levels of fibrin generation are not altered by continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA). A randomised, placebo-controlled crossover study.

McEwen BJ, Phillips CL, Morel-Kopp MC, Yee BJ, Sullivan DR, Ward CM, Tofler GH, Grunstein RR.

Thromb Haemost. 2012 Oct;108(4):701-9. Epub 2012 Aug 23. Erratum in: Thromb Haemost. 2013 Oct 31;110(5):1085.

PMID:
22918526

Supplemental Content

Support Center